Skip to main content

Table 1 Baseline characteristics of the study cohort and the calculated metabolic syndrome prevalence

From: Prevalence of metabolic syndrome in Saudi Arabia - a cross sectional study

Total
12,126
Men
5571(45.94)
Women
6555(54.06)
P value
Discreptive analysis; mean (± SD)  
 Mean age (years) 35.7 (±15.0) 36.1 (±15.2) 35.5 (±14.8) P value
 Mean WC (cm) 87.0 (±16.7) 89.71 ± 17.11 84.75 ± 16.03 0.035
 Mean Hip (cm) 99.1 (±16.8) 98.7 (±16.8) 99.4(±16.8) < 0.001
 Mean W-H ratio 0.9 (±0.12) 0.9(±0.1) 0.9 (±0.1) 0.014
 Mean Systolic Bp (mmHg) 117.7 (±13.8) 119.7 (±13.1) 116.0 (±14.1) < 0.001
 Mean Diastolic Bp (mmHg) 76.1 (±8.6) 77.3 (±8.9) 75.2 (±8.7) < 0.001
 Mean FPG (mmol/L) 5.7 (±2.4) 5.8 (±2.6) 5.6 (±2.3) < 0.001
 Mean LDL Cholesterol (mmol/L) 3.2 (±1.1) 3.2 (±1.1) 3.2 (±1.0) < 0.001
 Mean triglyceride (mmol/L) 1.6 (±1.2) 1.8 (±1.3) 1.5 (±0.1) 0.012
 Mean HDL cholesterol (mmol/L) 0.1 (±0.3) 0.9 (±0.3) 1.0 (±0.3) < 0.001
Frequancy anlysis; number (%)
 Age groups: 18-29 years 5196 (42.9) 2328(41.8) 2868(43.8) < 0.001
 30-39 years 2660 (21.9) 1276(22.9) 1384(21.1)
 40-49 years 2207 (18.2) 942(16.9) 1265(19.3)
 50-59 years 1086 (8.1) 524(9.4) 562(8.6)
 60-69 years 573(4.7) 315(5.7) 258(3.9)
  ≥ 70 years 404(3.3) 186(3.3) 218(3.3)
 BMI groups < 18.5 673(5.6) 315(5.7) 358(5.5) < 0.001
 18.5-24.9 3783(31.2) 1807(32.4) 1976(30.1)
 25-29.9 3642(30.0) 1812(32.5) 1830(27.9)
  ≥ 30 4028(33.2) 1637(29.4) 2391(36.5)
 Monthly Income < 4000 SR 5255(43.3) 2175(39.0) 3080(46.1) < 0.001
 4000-8000 SR 4438(36.6) 2173(39.0) 2265(34.6)
  > 8000 SR 2433(20.1) 1223(21.95) 1210(18.46)
 Smoking 1564(12.9) 1475(26.5) 89(1.4) < 0.001
 Educational level: Illiterate 2417(19.9) 554(9.94) 1863(28.42)
 Less than high school 3648(30.1) 1855(33.3) 1793(27.4)
 More than or equal high school 6061(49.1) 3162(56.8) 2899(44.2)
 Family history of: Diabetes Mellitus 6200(51.1) 2896(51.1) 3304(50.4) 0.083
 Hypertension 4212(34.7) 1887(33.9) 2325(35.5) 0.066
Metabolic Syndrome Prevalence
 IDF criteria (WC + ≥ 2risk factors) 3833(31.6) 1917(34.4) 1916(29.2) < 0.001
 NCEP-ATP-III criteria (3 or more risk factors) 4828(39.8) 2507(45.0) 2321(35.4) < 0.001
  1. NCEP-ATP-III;, National Cholesterol Education Program and Adult Treatment Panel III, HDL; high density lipoprotein, IDF; International Diabetes Federation, LDL; low density lipoprotein, WC; waist circumference, WHR; waist-to-hip ratio